Profile
Harry Welten is currently Chief Executive Officer at AL-S Pharma AG since 2026.
Holds director positions at BioSupport AG and Kanyos Bio, Inc. Since 2023, Chief Financial Officer at Affimed NV, where employment began in 2020.
Member of the Management Board at Horizon Therapeutics Switzerland GmbH.
Member of the Foundation Council at Fondation De l'Hôpital Barrie Memorial and HBM Fondation.
Member of the Supervisory Board at Affimed GmbH.
Formerly Chairman at Novaremed AG from 2018 to 2020.
Served as Chairman and Director at Proteomedix AG.
Director roles at UBS Securities LLC, Kuros Biosurgery Holding AG, European Medical Solutions, Synosia Therapeutics, Inc., BiognoSYS AG, Anokion SA, Kuros Biosciences Ltd. in 2018, Kuros Biosciences AG, Virometix AG, and Synosia Therapeutics AG.
Chief Financial Officer and Executive Vice President at Cytos Biotechnology AG from 2011 to 2012, and Chief Financial Officer and Senior Vice President at Arpida AG in 2009.
Education includes undergraduate studies at Zurich School of Management and an MBA from Columbia Business School.
Harry Welten active positions
| Companies | Position | Start |
|---|---|---|
| AFFIMED N.V. | Director of Finance/CFO | 31/12/2023 |
AL-S Pharma AG
AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services | Chief Executive Officer | 14/10/2026 |
BioSupport AG | Director/Board Member | - |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Director/Board Member | - |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Director/Board Member | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Fondation De l'Hôpital Barrie Memorial
Fondation De l'Hôpital Barrie Memorial Miscellaneous Commercial ServicesCommercial Services Engages in raising funds to improve health care and services | Corporate Officer/Principal | - |
HBM Fondation | Corporate Officer/Principal | - |
Former positions of Harry Welten
| Companies | Position | End |
|---|---|---|
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Chairman | 02/10/2024 |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Education of Harry Welten
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration | Commercial Services |
Arpida AG
Arpida AG BiotechnologyHealth Technology Develops and manufactures novel drugs | Health Technology |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
European Medical Solutions
European Medical Solutions BiotechnologyHealth Technology Develops tools for diagnosis and treatment of immune response-related diseases | Health Technology |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
BiognoSYS AG
BiognoSYS AG Packaged SoftwareTechnology Services Provides software and data platforms for life science researchers, biomarkers and drug developers | Technology Services |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Health Technology |
Zurich School of Management
Zurich School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
BioSupport AG | |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Fondation De l'Hôpital Barrie Memorial
Fondation De l'Hôpital Barrie Memorial Miscellaneous Commercial ServicesCommercial Services Engages in raising funds to improve health care and services | Commercial Services |
Kuros Biosciences Ltd.
Kuros Biosciences Ltd. Medical SpecialtiesHealth Technology Manufactures medical device technology and provides clinical research development services | Health Technology |
HBM Fondation | |
AL-S Pharma AG
AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services | Commercial Services |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
Kuros Biosciences AG
Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Develops products for tissue repair and regeneration | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
- Stock Market
- Insiders
- Harry Welten
















